SOLIGENIX, INC. (SNGX)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenues | - | - | 2,342 | |
| Cost of revenue | - | - | 2,342 | |
| Gross profit | - | - | - | |
| Research and development | 1,677,014 | 968,689 | 501,158 | |
| General and administrative | 1,086,865 | 896,547 | 1,243,517 | |
| Total operating expenses | 2,763,879 | 1,865,236 | 1,744,675 | |
| Loss from operations | -2,763,879 | -1,865,236 | -1,744,675 | |
| Other nonoperating income (expense) | - | - | 43 | |
| Uk research and development incentives | - | - | 31,819 | |
| Amount of expense (income) related to adjustment to fair value of convertible debt | - | - | -95,551 | |
| Amount of income related to employee retention credit under cares act | - | 66,444 | - | |
| Other income | 125 | - | - | |
| Interest income, net | 69,823 | 78,836 | 35,925 | |
| Foreign currency transaction (loss) gain | -8,045 | 575 | 473 | |
| Total other income | 61,903 | 145,855 | 100,173 | |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | - | -1,719,381 | -1,644,502 | |
| Net loss applicable to common stockholders | -2,701,976 | -1,719,381 | -1,644,502 | |
| Earnings per share, basic | -0.82 | -0.78 | -1.31 | |
| Earnings per share, diluted | -0.82 | -0.78 | -1.31 | |
| Weighted average number of shares outstanding, basic | 3,278,677 | 2,203,929 | 1,258,985 | |
| Weighted average number of shares outstanding, diluted | 3,278,677 | 2,203,929 | 1,258,985 | |